Jacques Banchereau, Ph.D. is a Professor and Director of Immunological Sciences at The Jackson Laboratory – Genomic Medicine campus in Farmington, Connecticut. He has over 35 years of expertise in human immunology research with a strong track record of over 500 research publications. His research lab is currently leading discoveries in the field of cancer, vaccines, and human autoimmune diseases.
His ongoing studies include using long-read sequencing and genomic profiling technologies to reveal novel cancer isoforms that may serve as vaccine targets; identifying signatures of pediatric autoimmunity; responses to pneumococcal vaccination in the elderly; and responsiveness to vaccine adjuvants. Previously, he contributed to the discovery of IL-4, IL-10 and GM-CSF, and developed DC-based vaccines for melanoma and HIV treatment. Additionally, together with Virginia Pascual, M.D. (Director of the Drukier Institute for Children’s Health at Weill Cornell Medicine), he identified the role of type I interferon in SLE and IL-1 in SOJIA, leading to the application of IL-1 antagonists for juvenile arthritic disease.